Xilong Historical Income Statement

002584 Stock

8.12 0.22 2.64%

Historical analysis of Xilong Chemical income statement accounts such as Selling General Administrative of 79.2 M, Total Revenue of 9.3 B or Operating Income of 111.9 M can show how well Xilong Chemical Co performed in making a profits. Evaluating Xilong Chemical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Xilong Chemical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Xilong Chemical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xilong Chemical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xilong Chemical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Xilong Income Statement Analysis

Xilong Chemical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Xilong Chemical shareholders. The income statement also shows Xilong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Xilong Chemical Income Statement Chart

At present, Xilong Chemical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 9.3 B, whereas Selling General Administrative is forecasted to decline to about 79.2 M.

Selling General Administrative Total Revenue Operating Income Cost Of Revenue

Total Revenue

Total revenue comprises all receipts Xilong Chemical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Xilong Chemical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Xilong Chemical Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Xilong Chemical income statement and represents the costs associated with goods and services Xilong Chemical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Xilong Chemical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Xilong Chemical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xilong Chemical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Operating Income	128.1M	144.7M	166.4M	111.9M
Total Revenue	6.2B	7.7B	8.8B	9.3B

Operating Income Total Revenue

Xilong Chemical income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		-0.54	-0.23	-0.56	0.26	0.23	0.46	0.57	-0.32	-0.16	-0.53	0.2	-0.21	-0.61	0.01	0.31	0.45	-0.22	-0.4	-0.62
Total Revenue	-0.54		0.74	1.0	-0.03	-0.04	-0.19	-0.21	0.85	0.7	0.55	-0.24	-0.06	0.91	-0.29	-0.73	-0.86	0.12	0.72	0.62
Operating Income	-0.23	0.74		0.74	0.52	0.5	0.01	-0.08	0.78	0.57	0.54	0.25	0.26	0.8	-0.14	-0.58	-0.63	0.14	0.83	0.52
Cost Of Revenue	-0.56	1.0	0.74		-0.04	-0.04	-0.19	-0.23	0.84	0.68	0.56	-0.24	-0.05	0.91	-0.28	-0.72	-0.85	0.14	0.72	0.63
Income Before Tax	0.26	-0.03	0.52	-0.04		0.99	0.18	-0.04	0.16	0.08	0.12	0.9	0.33	0.03	0.14	0.05	0.04	0.14	0.55	-0.2
Net Income	0.23	-0.04	0.5	-0.04	0.99		0.07	-0.07	0.17	0.14	0.05	0.91	0.34	0.03	0.08	-0.02	0.02	0.04	0.56	-0.18
Income Tax Expense	0.46	-0.19	0.01	-0.19	0.18	0.07		0.48	-0.32	-0.42	0.07	0.0	-0.15	-0.33	0.61	0.58	0.45	0.33	-0.32	-0.29
Minority Interest	0.57	-0.21	-0.08	-0.23	-0.04	-0.07	0.48		0.03	0.03	-0.32	-0.25	-0.35	-0.27	-0.03	0.15	0.08	0.04	-0.43	-0.47
Research Development	-0.32	0.85	0.78	0.84	0.16	0.17	-0.32	0.03		0.84	0.43	-0.07	-0.08	0.86	-0.51	-0.79	-0.94	0.02	0.74	0.37
Gross Profit	-0.16	0.7	0.57	0.68	0.08	0.14	-0.42	0.03	0.84		0.13	-0.1	-0.19	0.62	-0.58	-0.87	-0.84	-0.3	0.64	0.19
Other Operating Expenses	-0.53	0.55	0.54	0.56	0.12	0.05	0.07	-0.32	0.43	0.13		0.03	0.43	0.66	0.42	-0.05	-0.39	0.36	0.51	0.42
Net Income From Continuing Ops	0.2	-0.24	0.25	-0.24	0.9	0.91	0.0	-0.25	-0.07	-0.1	0.03		0.37	-0.13	0.17	0.2	0.23	0.16	0.47	-0.25
Ebit	-0.21	-0.06	0.26	-0.05	0.33	0.34	-0.15	-0.35	-0.08	-0.19	0.43	0.37		0.12	0.35	0.04	0.09	-0.13	0.25	0.35
Total Operating Expenses	-0.61	0.91	0.8	0.91	0.03	0.03	-0.33	-0.27	0.86	0.62	0.66	-0.13	0.12		-0.28	-0.7	-0.83	0.17	0.75	0.71
Total Other Income Expense Net	0.01	-0.29	-0.14	-0.28	0.14	0.08	0.61	-0.03	-0.51	-0.58	0.42	0.17	0.35	-0.28		0.7	0.58	0.22	-0.23	-0.13
Tax Provision	0.31	-0.73	-0.58	-0.72	0.05	-0.02	0.58	0.15	-0.79	-0.87	-0.05	0.2	0.04	-0.7	0.7		0.82	0.41	-0.61	-0.52
Net Interest Income	0.45	-0.86	-0.63	-0.85	0.04	0.02	0.45	0.08	-0.94	-0.84	-0.39	0.23	0.09	-0.83	0.58	0.82		0.02	-0.67	-0.36
Interest Income	-0.22	0.12	0.14	0.14	0.14	0.04	0.33	0.04	0.02	-0.3	0.36	0.16	-0.13	0.17	0.22	0.41	0.02		0.12	0.0
Ebitda	-0.4	0.72	0.83	0.72	0.55	0.56	-0.32	-0.43	0.74	0.64	0.51	0.47	0.25	0.75	-0.23	-0.61	-0.67	0.12		0.41
Reconciled Depreciation	-0.62	0.62	0.52	0.63	-0.2	-0.18	-0.29	-0.47	0.37	0.19	0.42	-0.25	0.35	0.71	-0.13	-0.52	-0.36	0.0	0.41

Click cells to compare fundamentals

Xilong Chemical Account Relationship Matchups

Xilong Chemical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	65.1M	67.5M	49.1M	60.9M	70.0M	73.5M
Selling General Administrative	161.5M	158.4M	53.6M	72.5M	83.4M	79.2M
Total Revenue	6.2B	6.8B	6.2B	7.7B	8.8B	9.3B
Operating Income	127.6M	194.2M	128.1M	144.7M	166.4M	111.9M
Cost Of Revenue	5.8B	6.3B	5.7B	7.2B	8.3B	8.7B
Income Before Tax	81.2M	227.3M	102.7M	42.9M	49.4M	46.9M
Net Income Applicable To Common Shares	70.6M	38.5M	56.9M	203.9M	234.5M	246.2M
Net Income	56.9M	203.9M	89.1M	33.3M	38.3M	36.4M
Income Tax Expense	5.6M	11.4M	17.6M	9.3M	10.7M	15.3M
Minority Interest	71.6M	(14.1M)	1.4M	(1.2M)	(1.1M)	(1.1M)
Research Development	102.7M	119.0M	90.5M	95.7M	110.1M	84.6M
Gross Profit	479.5M	557.4M	441.5M	470.1M	540.6M	528.6M
Other Operating Expenses	1.1M	13.6M	14.1M	16.0M	18.4M	12.3M
Net Income From Continuing Ops	63.7M	217.9M	87.7M	34.6M	39.8M	37.8M
Ebit	101.1M	116.3M	75.0M	142.9M	128.6M	91.8M
Total Operating Expenses	6.1B	6.6B	6.1B	7.5B	8.7B	5.0B
Tax Provision	17.6M	9.3M	15.0M	8.3M	7.5M	10.5M
Net Interest Income	(58.6M)	(69.1M)	(58.5M)	(70.2M)	(63.2M)	(66.4M)
Interest Income	12.5M	7.0M	9.1M	5.7M	6.5M	7.3M
Ebitda	135.5M	176.2M	329.5M	196.3M	225.7M	208.6M
Reconciled Depreciation	29.9M	34.8M	44.5M	49.3M	56.7M	39.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Other Information on Investing in Xilong Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xilong Historical Income Statement

About Xilong Income Statement Analysis

Xilong Chemical Income Statement Chart

Total Revenue

Operating Income

Cost Of Revenue

Xilong Chemical income statement Correlations

Xilong Chemical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Xilong Chemical income statement Accounts

Also Currently Popular

Other Information on Investing in Xilong Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Total Revenue
Net Income	+ 0.99	Income Before Tax
Total Operating Expenses	+ 0.91	Total Revenue
Total Operating Expenses	+ 0.91	Cost Of Revenue
Net Income From Continuing Ops	+ 0.91	Net Income
Net Income From Continuing Ops	+ 0.9	Income Before Tax

Net Interest Income	- 0.94	Research Development
Tax Provision	- 0.87	Gross Profit
Net Interest Income	- 0.86	Total Revenue
Net Interest Income	- 0.85	Cost Of Revenue
Net Interest Income	- 0.84	Gross Profit
Net Interest Income	- 0.83	Total Operating Expenses